Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04575402 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Digitally Captured Activity Data and PROs to Monitor Physical Function in Prostate Cancer Patients

Study acronym: DigiPRO
StatusUnknown
PhaseNot specified
Started2021-02-19
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 27, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.

Amendment history

2026-09-06
Trial status changed: Active, Not Recruiting → Unknown
2024-08-23
Recruiting→Active, Not Recruiting Study Status, Contacts/Locations v4
Trial statusRecruiting→Unknown
Primary completion date2022-09-30→2024-12-31
Completion date2022-12-31→2024-12-31
Study sitesdetails revised at 1 of 1 site
2021-07-27
Study Status, Contacts/Locations v3
Study sitescontacts updated at 1 of 1 site
2021-06-18
Not Yet Recruiting→Recruiting Study Status, Eligibility, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2021-02-01→confirmed 2021-02-19
Eligibility criteria+103 characters
Inclusion Criteria: Prostate cancer patients receiving ADT (+/- radiation) or planning to receive ADT. Start date of ADT must be planned for no more 7 days after baseline, or patients must have started ADT within 6 months prior to enrollment. 18 years or older Ambu [...] ds, cochlear implants, or other electronic medical equipment*. However, removable hearing aids are permitted.
Study sitesdetails revised at 1 of 1 site
2020-12-28
Study Status, Contacts/Locations v1
Primary completion date2022-05-31→2022-09-30
Completion date2022-08-31→2022-12-31
Start date2020-11-01→2021-02-01
Study sites0→1
2020-09-29
Original filing
Prospective observational research study to evaluate the role of wearable activity monitors to predict physical function decline among prostate cancer survivors receiving ADT.
Trial Details
NCT Number NCT04575402
Lead Sponsor Cedars-Sinai Medical Center
Collaborators: United States Department of Defense
Conditions Prostate Cancer
Enrollment 40 participants
Start Date 2021-02-19
Primary Completion 2024-12-31 (estimated)
Study Completion 2024-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-08-27